Clinical Trials
5 trialsNCT05772273 2025-11-21
PD-1 Inhibitor, Azacitidine and Low-dose DLI in AML Relapse After Allo-HSCT
The First Affiliated Hospital of Soochow University
Phase NA Recruiting
NCT07131059 2025-08-20
MRD-positive AML Clinical Study
Institute of Hematology & Blood Diseases Hospital, China
Phase NA Recruiting
NCT06386302 2025-08-03
Chidamide, Venetoclax, and Azacitidine for Newly Diagnosed Acute Myeloid Leukemia
Institute of Hematology & Blood Diseases Hospital, China
Phase NA Recruiting
NCT06256627 2024-02-13
The Maintenance Treatment of "ITIVA" in AML Patients
Henan Cancer Hospital
Phase NA Recruiting
NCT06066905 2023-10-27
A Study of Chidamide With AZA in MRD Positive AML After Transplant
Guangdong Provincial People's Hospital
Phase NA Recruiting